Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice

Previous studies have shown that <i>Dendrobium nobile</i> Lindl. alkaloids (DNLAs) have neuroprotective effects in several Alzheimer’s disease (AD) models. Dendrobine (DDB) is one of the monomer components with the highest content in DNLAs. However, the effects of DDB on cognitive impair...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Juan Huang, Jingshan Shi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/14/3/231
_version_ 1827306810083639296
author Wei Zhang
Juan Huang
Jingshan Shi
author_facet Wei Zhang
Juan Huang
Jingshan Shi
author_sort Wei Zhang
collection DOAJ
description Previous studies have shown that <i>Dendrobium nobile</i> Lindl. alkaloids (DNLAs) have neuroprotective effects in several Alzheimer’s disease (AD) models. Dendrobine (DDB) is one of the monomer components with the highest content in DNLAs. However, the effects of DDB on cognitive impairments in AD remain unknown. In this study, we investigated the efficacy of DDB in 3 × Tg-AD mice to determine whether DDB was a key component of the anti-AD effect of DNLAs. Five-month mice were intragastrically administrated with DDB (10 and 20 mg/kg/d) or DNLAs (20 mg/kg/d) for seven consecutive months, and the effects of DDB and DNLAs were evaluated at twelve months. The results revealed that 3 × Tg-AD mice treated with DDB showed enhanced nesting ability. DDB also effectively rescued spatial learning and memory deficits in 3 × Tg-AD mice. Meanwhile, DDB treatment prevented the loss of dendritic spine density, with increased expression levels of synaptophysin, PSD95, and NCAM in the hippocampus. Finally, DDB ameliorated the increase in APP, sAPPβ, CTF-β, and β-amyloid peptides, accompanied by the promotion of GSK phosphorylation at the Ser9 site, thereby reducing hyperphosphorylated tau levels. As the active component of DNLA, DDB can preserve cognitive function, alleviate neuronal and synaptic defects, and improve APP/tau pathology in 3 × Tg-AD mice.
first_indexed 2024-04-24T18:28:44Z
format Article
id doaj.art-19b2f955793d455fa3349f46281c171d
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-04-24T18:28:44Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-19b2f955793d455fa3349f46281c171d2024-03-27T13:28:42ZengMDPI AGBrain Sciences2076-34252024-02-0114323110.3390/brainsci14030231Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD MiceWei Zhang0Juan Huang1Jingshan Shi2Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, ChinaKey Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, ChinaKey Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, ChinaPrevious studies have shown that <i>Dendrobium nobile</i> Lindl. alkaloids (DNLAs) have neuroprotective effects in several Alzheimer’s disease (AD) models. Dendrobine (DDB) is one of the monomer components with the highest content in DNLAs. However, the effects of DDB on cognitive impairments in AD remain unknown. In this study, we investigated the efficacy of DDB in 3 × Tg-AD mice to determine whether DDB was a key component of the anti-AD effect of DNLAs. Five-month mice were intragastrically administrated with DDB (10 and 20 mg/kg/d) or DNLAs (20 mg/kg/d) for seven consecutive months, and the effects of DDB and DNLAs were evaluated at twelve months. The results revealed that 3 × Tg-AD mice treated with DDB showed enhanced nesting ability. DDB also effectively rescued spatial learning and memory deficits in 3 × Tg-AD mice. Meanwhile, DDB treatment prevented the loss of dendritic spine density, with increased expression levels of synaptophysin, PSD95, and NCAM in the hippocampus. Finally, DDB ameliorated the increase in APP, sAPPβ, CTF-β, and β-amyloid peptides, accompanied by the promotion of GSK phosphorylation at the Ser9 site, thereby reducing hyperphosphorylated tau levels. As the active component of DNLA, DDB can preserve cognitive function, alleviate neuronal and synaptic defects, and improve APP/tau pathology in 3 × Tg-AD mice.https://www.mdpi.com/2076-3425/14/3/231Dendrobinespatial memorysynaptic lossβ-amyloidtau
spellingShingle Wei Zhang
Juan Huang
Jingshan Shi
Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
Brain Sciences
Dendrobine
spatial memory
synaptic loss
β-amyloid
tau
title Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
title_full Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
title_fullStr Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
title_full_unstemmed Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
title_short Dendrobine Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice
title_sort dendrobine ameliorates alzheimer s disease like pathology and cognitive decline in 3 tg ad mice
topic Dendrobine
spatial memory
synaptic loss
β-amyloid
tau
url https://www.mdpi.com/2076-3425/14/3/231
work_keys_str_mv AT weizhang dendrobineamelioratesalzheimersdiseaselikepathologyandcognitivedeclinein3tgadmice
AT juanhuang dendrobineamelioratesalzheimersdiseaselikepathologyandcognitivedeclinein3tgadmice
AT jingshanshi dendrobineamelioratesalzheimersdiseaselikepathologyandcognitivedeclinein3tgadmice